Cargando…
Treatment Inertia in Patients With Familial Hypercholesterolemia
BACKGROUND: We studied care gap in patients with familial hypercholesterolemia (FH) with respect to lipid‐lowering therapy. METHODS AND RESULTS: We enrolled patients with cardiovascular disease (CVD) or FH and low‐density lipoprotein‐cholesterol >2.0 mmol/L despite maximally tolerated statin ther...
Autores principales: | Langer, Anatoly, Mancini, G. B. John, Tan, Mary, Goodman, Shaun G., Ahooja, Vineeta, Grégoire, Jean, Lin, Peter J., Stone, James A., Leiter, Lawrence A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483494/ https://www.ncbi.nlm.nih.gov/pubmed/34238023 http://dx.doi.org/10.1161/JAHA.120.020126 |
Ejemplares similares
-
GOAL Canada: Physician Education and Support Can Improve Patient Management
por: Langer, Anatoly, et al.
Publicado: (2019) -
Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome
por: Fitchett, David H., et al.
Publicado: (2020) -
Nonadherence, Clinical Inertia, or Therapeutic Inertia?
por: Allen, J. Daniel, et al.
Publicado: (2009) -
Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report
por: Dardano, Angela, et al.
Publicado: (2021) -
Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)